Jinghua Pharmaceutical Group Co., Ltd.

SZSE:002349.SZ

8.74 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 247.466276.467212.296139.95927.925-524.349260.069190.326173.4681.84240.62740.67359.61748.35142.63932.826.16325.59311.802
Depreciation & Amortization 76.50585.342109.928102.49983.99481.37180.3163.84259.80845.72439.64425.18417.2489.369.0489.84310.22611.23915.227
Deferred Income Tax 001.0474.2692.5463.21500-2.4890.331000000000
Stock Based Compensation 0000000000000000000
Change In Working Capital -22.627-81.041-4.94138.92519.41144.874-287.162-276.609116.808-210.77-39.823-141.081-3.716-20.508-11.42114.409-23.435-0.433-10.402
Accounts Receivables -11.167-40.564125.1769.282.32428.863-194.797-203.239217.542-174.25430.105-81.892-24.374000000
Inventory 6.43411.18-27.823-31.09446.322-6.172-22.938-126.996-75.098-28.597-37.572-59.491-3.695-7.036-18.0378.496-2.871-4.1813.433
Accounts Payables 0-46.608-103.34256.471-31.7818.9680000000000000
Other Working Capital -17.894-5.0491.0474.2692.5463.215-69.42790.534-27.175-7.91900.30221.564-13.4726.6165.913-20.5643.748-13.835
Other Non Cash Items 9.674041.10724.188196.888683.48632.104121.007-4.7357.1925.25420.28410.7754.2420.7930.7064.175-2.5365.555
Operating Cash Flow 311.018291.31358.39305.571328.218285.38283.4375.923343.802-76.01245.702-54.9477.24741.44541.0657.75817.12933.86322.182
Investing Activities:
Investments In Property Plant And Equipment -30.923-28.376-61.586-80.547-118.464-255.347-160.247-441.174-245.101-58.821-28.834-57.62-190.259-100.886-35.893-4.403-2.363-4.444-2.951
Acquisitions Net 00.26471.4120.41423.2115.677-5.3150-23.1770.26110.2330-63.115000000
Purchases Of Investments -665-627-531-400-102-4.950-0.005-49.137-357.158-15-0.180000000
Sales Maturities Of Investments 894.949442.89629.896407.71251.73614.9832.62600.47213.04220000001.0720
Other Investing Activites -304.835-7.135-0.1353.4522.109-5.7074.8340.2092.823.8697.89714.29141.05631.4080.2330012.2060.044
Investing Cash Flow -105.809-212.367108.587-68.971-123.408-245.344-158.102-440.97-314.143-378.808-23.705-43.51-212.318-69.478-35.66-4.403-2.3638.833-2.907
Financing Activities:
Debt Repayment -10.9-0.1-78.375-107.598-213.99995.6889270-90-103957.2-25.70-25-5-10-21.03-15
Common Stock Issued 0000000040000000000
Common Stock Repurchased 000000-132.207000000000000
Dividends Paid -75.545-65.984-48.851-44.501-19.954-61.006-57.375-69.135-30.817-29.415-14.171-12.88-13.293-8-8.042-15.993-2.893-8.039-8.934
Other Financing Activities -21.576-28.076-54.82-44.515313.72815.532-131.436172.451-9.604101.356682.713-4.9530.2372.3550000
Financing Cash Flow -108.022-94.16-182.046-176.21479.77550.205-99.812373.316-126.42161.941707.54239.37-35.993-7.8339.313-20.993-12.893-29.069-23.934
Other Information:
Effect Of Forex Changes On Cash 2.1331.9974.097-1.117-5.5980.21.32-1.580.1880.629-0.01-0.183-0.172-0.004-0.003-0-0.027-0.638-0.393
Net Change In Cash 99.321-13.22289.02859.269278.98790.443-173.1646.688-96.574-392.249729.529-59.263-171.235-35.838344.7132.3611.84612.99-5.052
Cash At End Of Period 1,013.521914.199927.42638.391579.122300.135209.692382.855376.167472.74864.99135.461194.724365.959401.79757.08724.72622.889.89